Inositol 1,4,5-trisphosphate receptor type 2 is associated with the bone–vessel axis in chronic kidney disease–mineral bone disorder

References

• GBD, Collaboration; CKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822.
   PubMed Web of Science ®Google Scholar
• Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69(11):1945–1953.
   PubMed Web of Science ®Google Scholar
• Cheng X, Nayyar S, Wang M, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant. 2013;28(3):724–732.
   PubMed Web of Science ®Google Scholar
• de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782–1789.
   PubMed Web of Science ®Google Scholar
• Sekercioglu N, Busse JW, Mustafa RA, et al. Cinacalcet versus standard treatment for chronic kidney disease: a protocol for a systematic review and meta-analysis. Syst Rev. 2016;5:2.
   PubMedGoogle Scholar
• Liu ZH, Li G, Zhang L, et al. Executive summary: clinical practice guideline of chronic kidney disease - mineral and bone disorder (CKD-MBD) in China. Kidney Dis. 2019;5(4):197–203.
   Google Scholar
• Moe SM, Drüeke T, Lameire N, et al. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007;14(1):3–12.
   PubMed Web of Science ®Google Scholar
• Babayev R, Nickolas TL. Bone disorders in chronic kidney disease: an update in diagnosis and management. Semin Dial. 2015;28(6):645–653.
   PubMed Web of Science ®Google Scholar
• Daimon M, Fujita T, Murabayashi M, et al. Exacerbation of hyperparathyroidism, secondary to a reduction in kidney function, in individuals with vitamin D deficiency. Front Med. 2020;7:221.
   Web of Science ®Google Scholar
• Chen L, Tang X, Zheng H, et al. Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study. Ren Fail. 2022;44(1):336–345.
   PubMed Web of Science ®Google Scholar
• Witham MD, Lees JS, White M, et al. Vitamin K supplementation to improve vascular stiffness in CKD: the K4Kidneys randomized controlled trial. J Am Soc Nephrol. 2020;31(10):2434–2445.
   PubMed Web of Science ®Google Scholar
• Ok E, Asci G, Bayraktaroglu S, et al. Reduction of dialysate calcium level reduces progression of coronary artery calcification and improves low bone turnover in patients on hemodialysis. J Am Soc Nephrol. 2016;27(8):2475–2486.
   PubMed Web of Science ®Google Scholar
• London GM, Marchais SJ, Guérin AP, et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol. 2008;19(9):1827–1835.
   PubMed Web of Science ®Google Scholar
• Garland JS, Holden RM, Groome PA, et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis. 2008;52(5):849–858.
   PubMed Web of Science ®Google Scholar
• Neves KR, Graciolli FG, dos Reis LM, et al. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int. 2004;66(6):2237–2244.
   PubMed Web of Science ®Google Scholar
• Ferrari GO, Ferreira JC, Cavallari RT, et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models. BMC Nephrol. 2014;15:69.
   PubMed Web of Science ®Google Scholar
• Neven E, D'Haese PC. Vascular calcification in chronic renal failure: what have we learned from animal studies? Circ Res. 2011;108(2):249–264.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Tang Y, Xia J, et al. Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells. Ren Fail. 2022;44(1):752–766.
   PubMed Web of Science ®Google Scholar
• Wang C, Tang Y, Wang Y, et al. Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification. Ren Fail. 2019;41(1):220–228.
   PubMed Web of Science ®Google Scholar
• Bouxsein ML, Boyd SK, Christiansen BA, et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468–1486.
   PubMed Web of Science ®Google Scholar
• Caron MMJ, Castermans TMR, van Rietbergen B, et al. Impairment of cyclo-oxygenase-2 function results in abnormal growth plate development and bone microarchitecture but does not affect longitudinal growth of the long bones in skeletally immature mice. Cartilage. 2021;12(3):387–398.
   PubMedGoogle Scholar
• Wang L, Zheng J, Pathak JL, et al. SLIT2 overexpression in periodontitis intensifies inflammation and alveolar bone loss, possibly via the activation of MAPK pathway. Front Cell Dev Biol. 2020;8:593.
   PubMed Web of Science ®Google Scholar
• Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J Immunol Methods. 2013;394(1-2):49–54.
   PubMed Web of Science ®Google Scholar
• Cui J, Shen N, Lu Z, et al. Analysis and comprehensive comparison of PacBio and nanopore-based RNA sequencing of the Arabidopsis transcriptome. Plant Methods. 2020;16:85.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhong Y, Cheng J, et al. EnrichVisBox: a versatile and powerful web toolbox for visualizing complex functional enrichment results of omics data. J Comput Biol. 2021;28(9):922–930.
   PubMed Web of Science ®Google Scholar
• Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Favero C, Carriazo S, Cuarental L, et al. Phosphate, microbiota and CKD. Nutrients. 2021;13(4):1273.
   PubMed Web of Science ®Google Scholar
• Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and klotho. Bone. 2017;100:87–93.
   PubMed Web of Science ®Google Scholar
• Isakova T, Ix JH, Sprague SM, et al. Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol. 2015;26(10):2328–2339.
   PubMed Web of Science ®Google Scholar
• Haarhaus M, Cianciolo G, Barbuto S, et al. Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients. 2022;14(10):2124.
   PubMed Web of Science ®Google Scholar
• Salam S, Gallagher O, Gossiel F, et al. Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease. Bone. 2021;143:115699.
   PubMed Web of Science ®Google Scholar
• Kalaska B, Pawlak K, Domaniewski T, et al. Elevated levels of peripheral kynurenine decrease bone strength in rats with chronic kidney disease. Front Physiol. 2017;8:836.
   PubMed Web of Science ®Google Scholar
• Heveran CM, Schurman CA, Acevedo C, et al. Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice. Bone. 2019;127:91–103.
   PubMed Web of Science ®Google Scholar
• Miyata Y, Obata Y, Mochizuki Y, et al. Periodontal disease in patients receiving dialysis. IJMS. 2019;20(15):3805.
   Google Scholar
• Kitamura M, Mochizuki Y, Miyata Y, et al. Pathological characteristics of periodontal disease in patients with chronic kidney disease and kidney transplantation. IJMS. 2019;20(14):3413.
   Google Scholar
• Evenepoel P, Cavalier E, D'Haese PC. Biomarkers predicting bone turnover in the setting of CKD. Curr Osteoporos Rep. 2017;15(3):178–186.
   PubMed Web of Science ®Google Scholar
• Valverde P, Tu Q, Chen J. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res. 2005;20(9):1669–1679.
   PubMed Web of Science ®Google Scholar
• Szulc P. Bone turnover: biology and assessment tools. Best PR act Res Clin Endocrinol Metab. 2018;32(5):725–738.
   PubMed Web of Science ®Google Scholar
• Asadipooya K, Abdalbary M, Ahmad Y, et al. Bone quality in CKD patients: current concepts and future directions - part I. Kidney Dis. 2021;7(4):268–277.
   Google Scholar
• Wu S, Lu Q, Wang Q, et al. Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo. Circulation. 2017;136(23):2248–2266.
   PubMed Web of Science ®Google Scholar
• Ziegler DV, Vindrieux D, Goehrig D, et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nat Commun. 2021;12(1):720.
   PubMed Web of Science ®Google Scholar
• Schulte A, Bieniussa L, Gupta R, et al. Homeostatic calcium fluxes, ER calcium release, SOCE, and calcium oscillations in cultured astrocytes are interlinked by a small calcium toolkit. Cell Calcium. 2022;101:102515.
   PubMed Web of Science ®Google Scholar
• Robinson LJ, Blair HC, Barnett JB, et al. Regulation of bone turnover by calcium-regulated calcium channels. Ann N Y Acad Sci. 2010;1192:351–357.
   PubMed Web of Science ®Google Scholar
• Li X, Wang Y, Gao M, et al. Metabolomics-driven of relationships among kidney, bone marrow and bone of rats with postmenopausal osteoporosis. Bone. 2022;156:116306.
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Hisatsune C, Nakamura T, et al. Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc Natl Acad Sci U S A. 2008;105(25):8643–8648.
   PubMed Web of Science ®Google Scholar
• Zhang D, Lin L, Yang B, et al. Knockdown of Tcirg1 inhibits large-osteoclast generation by down-regulating NFATc1 and IP3R2 expression. PLoS One. 2020;15(8):e0237354.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li Y, Ding H, et al. Hydrogen peroxide prevents vascular calcification induced ROS production by regulating nrf-2 pathway. Ren Fail. 2016;38(7):1099–1106.
   PubMed Web of Science ®Google Scholar